Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Mutations in the PCNA-binding site of CDKN1C inhibit cell proliferation by impairing the entry into S phase

Full text
Author(s):
Borges, Kleiton S. [1, 2] ; Arboleda, Valerie A. [1, 3] ; Vilain, Eric [1, 4, 5]
Total Authors: 3
Affiliation:
[1] Univ Calif Los Angeles, Dept Human Genet, David Geffen Sch Med UCLA, Los Angeles, CA 90095 - USA
[2] Univ Sao, Ribeirao Preto Med Sch, Dept Genet, BR-14049900 Ribeirao Preto, SP - Brazil
[3] Univ Calif Los Angeles, Dept Pathol & Lab Med, David Geffen Sch Med, Los Angeles, CA 90095 - USA
[4] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 - USA
[5] Univ Calif Los Angeles, David Geffen Sch Med, Dept Urol, Los Angeles, CA 90095 - USA
Total Affiliations: 5
Document type: Journal article
Source: CELL DIVISION; v. 10, MAR 28 2015.
Web of Science Citations: 1
Abstract

CDKN1C (also known as P57(kip2)) is a cyclin-dependent kinase inhibitor that functions as a negative regulator of cell proliferation through G1 phase cell cycle arrest. Recently, our group described gain-of-function mutations in the PCNA-binding site of CDKN1C that result in an undergrowth syndrome called IMAGe Syndrome (Intrauterine Growth Restriction, Metaphyseal dysplasia, Adrenal hypoplasia, and Genital anomalies), with life-threatening consequences. Loss-of-function mutations in CDKN1C have been identified in 5-10% of individuals with Beckwith-Wiedemann syndrome (BWS), an overgrowth disorder with features that are the opposite of IMAGe syndrome. Here, we investigate the effects of IMAGe-associated mutations on protein stability, cell cycle progression and cell proliferation. Mutations in the PCNA-binding site of CDKN1C significantly increase CDKN1C protein stability and prevent cell cycle progression into the S phase. Overexpression of either wild-type or BWS-mutant CDKN1C inhibited cell proliferation. However, the IMAGe-mutant CDKN1C protein decreased cell growth significantly more than both the wild-type or BWS protein. These findings bring new insights into the molecular events underlying IMAGe syndrome. (AU)

FAPESP's process: 12/09391-0 - Molecular investigation of the role of CDKN1C (p57KIP2) and its mutations in adrenal development and tumor
Grantee:Kleiton Silva Borges
Support type: Scholarships abroad - Research Internship - Doctorate